
Cellular Therapy (CT) Market Insights, Global Outlook and Forecast 2022-2028
The Global Cellular Therapy (CT) Market investigation report contains Types, Application & all logical and factual briefs about market Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like Gilead Sciences, Novartis, Osiris, Vericel Corporation, Vcanbio, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology, Golden Meditech, Guanhao Biotech
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Cellular therapy (CT) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
The latest research study released by Market IntelliX evaluates market size and forecasts of Cellular Therapy (CT) in Global, including the following market information:
Global Cellular Therapy (CT) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cellular Therapy (CT) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stem Cell Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cellular Therapy (CT) include Gilead Sciences, Novartis, Osiris, Vericel Corporation, Vcanbio, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology and Golden Meditech and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Cellular Therapy (CT) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Cellular Therapy (CT) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cellular Therapy (CT) Market Segment Percentages, by Type, 2021 (%)
Stem Cell
Non-Stem Cell
Global Cellular Therapy (CT) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cellular Therapy (CT) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Cellular Therapy (CT) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cellular Therapy (CT) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cellular Therapy (CT) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cellular Therapy (CT) revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Vcanbio
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Cellular Therapy (CT) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cellular Therapy (CT) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cellular Therapy (CT) Overall Market Size
2.1 Global Cellular Therapy (CT) Market Size: 2021 VS 2028
2.2 Global Cellular Therapy (CT) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cellular Therapy (CT) Players in Global Market
3.2 Top Global Cellular Therapy (CT) Companies Ranked by Revenue
3.3 Global Cellular Therapy (CT) Revenue by Companies
3.4 Top 3 and Top 5 Cellular Therapy (CT) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cellular Therapy (CT) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cellular Therapy (CT) Players in Global Market
3.6.1 List of Global Tier 1 Cellular Therapy (CT) Companies
3.6.2 List of Global Tier 2 and Tier 3 Cellular Therapy (CT) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cellular Therapy (CT) Market Size Markets, 2021 & 2028
4.1.2 Stem Cell
4.1.3 Non-Stem Cell
4.2 By Type - Global Cellular Therapy (CT) Revenue & Forecasts
4.2.1 By Type - Global Cellular Therapy (CT) Revenue, 2017-2022
4.2.2 By Type - Global Cellular Therapy (CT) Revenue, 2023-2028
4.2.3 By Type - Global Cellular Therapy (CT) Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cellular Therapy (CT) Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Cellular Therapy (CT) Revenue & Forecasts
5.2.1 By Application - Global Cellular Therapy (CT) Revenue, 2017-2022
5.2.2 By Application - Global Cellular Therapy (CT) Revenue, 2023-2028
5.2.3 By Application - Global Cellular Therapy (CT) Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Cellular Therapy (CT) Market Size, 2021 & 2028
6.2 By Region - Global Cellular Therapy (CT) Revenue & Forecasts
6.2.1 By Region - Global Cellular Therapy (CT) Revenue, 2017-2022
6.2.2 By Region - Global Cellular Therapy (CT) Revenue, 2023-2028
6.2.3 By Region - Global Cellular Therapy (CT) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cellular Therapy (CT) Revenue, 2017-2028
6.3.2 US Cellular Therapy (CT) Market Size, 2017-2028
6.3.3 Canada Cellular Therapy (CT) Market Size, 2017-2028
6.3.4 Mexico Cellular Therapy (CT) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cellular Therapy (CT) Revenue, 2017-2028
6.4.2 Germany Cellular Therapy (CT) Market Size, 2017-2028
6.4.3 France Cellular Therapy (CT) Market Size, 2017-2028
6.4.4 U.K. Cellular Therapy (CT) Market Size, 2017-2028
6.4.5 Italy Cellular Therapy (CT) Market Size, 2017-2028
6.4.6 Russia Cellular Therapy (CT) Market Size, 2017-2028
6.4.7 Nordic Countries Cellular Therapy (CT) Market Size, 2017-2028
6.4.8 Benelux Cellular Therapy (CT) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cellular Therapy (CT) Revenue, 2017-2028
6.5.2 China Cellular Therapy (CT) Market Size, 2017-2028
6.5.3 Japan Cellular Therapy (CT) Market Size, 2017-2028
6.5.4 South Korea Cellular Therapy (CT) Market Size, 2017-2028
6.5.5 Southeast Asia Cellular Therapy (CT) Market Size, 2017-2028
6.5.6 India Cellular Therapy (CT) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cellular Therapy (CT) Revenue, 2017-2028
6.6.2 Brazil Cellular Therapy (CT) Market Size, 2017-2028
6.6.3 Argentina Cellular Therapy (CT) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cellular Therapy (CT) Revenue, 2017-2028
6.7.2 Turkey Cellular Therapy (CT) Market Size, 2017-2028
6.7.3 Israel Cellular Therapy (CT) Market Size, 2017-2028
6.7.4 Saudi Arabia Cellular Therapy (CT) Market Size, 2017-2028
6.7.5 UAE Cellular Therapy (CT) Market Size, 2017-2028
7 Players Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Corporate Summary
7.1.2 Gilead Sciences Business Overview
7.1.3 Gilead Sciences Cellular Therapy (CT) Major Product Offerings
7.1.4 Gilead Sciences Cellular Therapy (CT) Revenue in Global Market (2017-2022)
7.1.5 Gilead Sciences Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Cellular Therapy (CT) Major Product Offerings
7.2.4 Novartis Cellular Therapy (CT) Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Osiris
7.3.1 Osiris Corporate Summary
7.3.2 Osiris Business Overview
7.3.3 Osiris Cellular Therapy (CT) Major Product Offerings
7.3.4 Osiris Cellular Therapy (CT) Revenue in Global Market (2017-2022)
7.3.5 Osiris Key News
7.4 Vericel Corporation
7.4.1 Vericel Corporation Corporate Summary
7.4.2 Vericel Corporation Business Overview
7.4.3 Vericel Corporation Cellular Therapy (CT) Major Product Offerings
7.4.4 Vericel Corporation Cellular Therapy (CT) Revenue in Global Market (2017-2022)
7.4.5 Vericel Corporation Key News
7.5 Vcanbio
7.5.1 Vcanbio Corporate Summary
7.5.2 Vcanbio Business Overview
7.5.3 Vcanbio Cellular Therapy (CT) Major Product Offerings
7.5.4 Vcanbio Cellular Therapy (CT) Revenue in Global Market (2017-2022)
7.5.5 Vcanbio Key News
7.6 Fujifilm Cellular Dynamics
7.6.1 Fujifilm Cellular Dynamics Corporate Summary
7.6.2 Fujifilm Cellular Dynamics Business Overview
7.6.3 Fujifilm Cellular Dynamics Cellular Therapy (CT) Major Product Offerings
7.6.4 Fujifilm Cellular Dynamics Cellular Therapy (CT) Revenue in Global Market (2017-2022)
7.6.5 Fujifilm Cellular Dynamics Key News
7.7 JCR Pharmaceuticals
7.7.1 JCR Pharmaceuticals Corporate Summary
7.7.2 JCR Pharmaceuticals Business Overview
7.7.3 JCR Pharmaceuticals Cellular Therapy (CT) Major Product Offerings
7.7.4 JCR Pharmaceuticals Cellular Therapy (CT) Revenue in Global Market (2017-2022)
7.7.5 JCR Pharmaceuticals Key News
7.8 Beike Biotechnology
7.8.1 Beike Biotechnology Corporate Summary
7.8.2 Beike Biotechnology Business Overview
7.8.3 Beike Biotechnology Cellular Therapy (CT) Major Product Offerings
7.8.4 Beike Biotechnology Cellular Therapy (CT) Revenue in Global Market (2017-2022)
7.8.5 Beike Biotechnology Key News
7.9 Golden Meditech
7.9.1 Golden Meditech Corporate Summary
7.9.2 Golden Meditech Business Overview
7.9.3 Golden Meditech Cellular Therapy (CT) Major Product Offerings
7.9.4 Golden Meditech Cellular Therapy (CT) Revenue in Global Market (2017-2022)
7.9.5 Golden Meditech Key News
7.10 Guanhao Biotech
7.10.1 Guanhao Biotech Corporate Summary
7.10.2 Guanhao Biotech Business Overview
7.10.3 Guanhao Biotech Cellular Therapy (CT) Major Product Offerings
7.10.4 Guanhao Biotech Cellular Therapy (CT) Revenue in Global Market (2017-2022)
7.10.5 Guanhao Biotech Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Cellular Therapy (CT) Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|